Halozyme Therapeutics (HALO) PT Lowered to $93 at Morgan Stanley
Morgan Stanley analyst Sean Laaman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)